Scholarlink

<p>Thymic stromal lymphopoietin (TSLP), initially described as a driver of type 2 helper T cell responses, can also act on dendritic cells (DCs) to promote the generation and accumulation of GATA3-expressing effector regulatory T (eT<sub>reg</sub>) cells in the context of cutaneous melanoma. In this study, using an experimental mouse model with induced TSLP expression by epidermal keratinocytes combined with genetic tools, we find that TSLP drives GATA3<sup>+</sup> eT<sub>reg</sub> cells through a specific migratory DC population where the co-stimulatory molecule OX40L is required. By conducting transcriptomic identity, lineage-traced ontogeny, surface marker expression and functional studies, we identified and characterized this DC population. Our data demonstrated that TSLP acts on transitional dendritic cell-derived DC2 to promote GATA3<sup>+</sup> eT<sub>reg</sub> cells, thus uncovering a previously unrecognized tolerogenic axis in promoting immunosuppression, which is likely conserved in humans, across contexts of inflammation and cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

TSLP promotes GATA3-expressing effector regulatory T cells via DC2 derived from transitional DCs

  • 期刊论文

  • 发表日期：

    2026年1月27日

查看全文
  • Marine Guivarch,
  • Pierre Meyer,
  • Antoine Braud,
  • Pierre Marschall,
  • Alicia Perrin,
  • Alexis Verdenet,
  • Thien Phong Vu Manh,
  • Pauline Santa,
  • Vanja Sisirak,
  • Ya-Li Zhang,
  • Eric Flatter,
  • Tao Ye,
  • Matthieu Jung,
  • Marie-Christine Birling,
  • Pierre Hener,
  • Justine Segaud,
  • Beatriz German,
  • Dan Lipsker,
  • Marc Dalod,
  • Mei Li

摘要

Thymic stromal lymphopoietin (TSLP), initially described as a driver of type 2 helper T cell responses, can also act on dendritic cells (DCs) to promote the generation and accumulation of GATA3-expressing effector regulatory T (eTreg) cells in the context of cutaneous melanoma. In this study, using an experimental mouse model with induced TSLP expression by epidermal keratinocytes combined with genetic tools, we find that TSLP drives GATA3+ eTreg cells through a specific migratory DC population where the co-stimulatory molecule OX40L is required. By conducting transcriptomic identity, lineage-traced ontogeny, surface marker expression and functional studies, we identified and characterized this DC population. Our data demonstrated that TSLP acts on transitional dendritic cell-derived DC2 to promote GATA3+ eTreg cells, thus uncovering a previously unrecognized tolerogenic axis in promoting immunosuppression, which is likely conserved in humans, across contexts of inflammation and cancer.